Pertussis toxin attenuates intracranial morphine self-administration

doi:10.1016/0091-3057(93)90563-9

Pharmacology Biochemistry and Behavior

Volume 46, Issue 3, November 1993, Pages 689-695

https://doi.org/10.1016/0091-3057(93)90563-9 Get rights and content

Abstract

Mu and delta opioid receptor subtypes are thought to mediate the reinforcing actions of opioids. Since these opioid receptors use pertussis toxin (PTX)-sensitive inhibitory G-proteins for signal transduction, we determined whether PTX would block the opioid reinforcement signals produced by intrahippocampal or intraventral tegmental area (VTA) injections of morphine in rats. Hippocampal PTX pretreatment prevented the acquisition of intrahippocampal morphine self-administration. Similarly, in rats previously trained to self-administer morphine in the VTA, PTX injections in the VTA abolished morphine self-administration behavior, while sparing behavior reinforced by food pellets. This result suggested that the toxin did not interfere generally with motor capacity but rather acted selectively to block morphine reinforcement. Inactivated PTX did not reduce VTA morphine self-administration, thus demonstrating that PTX blockade of opioid reinforcement is primarily due to enzymatic inactivation of inhibitory G-proteins. All these findings are consistent with the hypothesis that inhibitory G-proteins in the hippocampus and VTA mediate the reinforcing effects of opioid drugs.

References (40)

G.K. Aghajanian et al.
Pertussis toxin blocks the outward currents evoked by opiate and alpha₂-agonists in locus coeruleus neurons
Brain Res.
(1986)
A. Bechara et al.
Kappa receptors mediate the peripheral aversive effects of opiates
Pharmacol. Biochem. Behav.
(1987)
R.J. Bodnar et al.
Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus
Brain Res.
(1990)
M.A. Bozarth et al.
Electrolytic microinfusion transducer system: An alternative method of intracranial drug application
J. Neurosci. Methods
(1980)
M.A. Bozarth et al.
Intracranial self-administration of morphine into the ventral tegmental area
Life Sci.
(1981)
S-C.J.L. Chang et al.
Dissociation of opioid receptor upregulation and functional supersensitvity
Pharmacol. Biochem. Behav.
(1991)
S.R. Childers
Opioid receptor-coupled second messenger systems
Life Sci.
(1991)
S.M. Crain et al.
Pertussis toxin blocks depressant effects of opioid, monoaminergic and muscarinic agonists on dorsal-horn network responses in spinal cord-ganglion cultures
Brain Res.
(1987)
P. De Witte et al.
Kelatorphan, a potent enkephalinase inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-administration behaviour depending on the site of administration
Neuropharmacology
(1989)
T.V. Dunwiddie et al.
Pertussis toxin pretreatment antagonizes the actions of mu- and delta-opite agonists in hippocampal slices
Neurosci. Lett.
(1988)

K. Hoehn et al.

Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen

Eur. J. Pharmacol.

(1988)

R.B. Innis et al.

Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra

Brain Res.

(1987)

F. Jenck et al.

Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward

Brain Res.

(1987)

P. Leone et al.

Morphine-dopamine interaction: Ventral tegmental morphine increases nucleus accumbens dopamine release

Pharmacol. Biochem. Behav.

(1991)

E. Neer et al.

Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase

J. Biol. Chem.

(1984)

D. Parolaro et al.

Pertussis toxin inhibits morphine analgesia and prevents opiate dependence

Pharmacol. Biochem. Behav.

(1990)

P. Sanchez-Blazquez et al.

Pertussis toxin differentially reduces the efficacy of opioids to produce supraspinal analgesia in the mouse

Eur. J. Pharmacol.

(1988)

T.S. Shippenberg et al.

Motivational properties of opioids: Evidence that an activation of delta-receptors mediates reinforcement processes

Brain Res.

(1987)

J.D. Steketee et al.

Possible role for G-proteins in behavioral sensitization to cocaine

Brain Res.

(1991)

K.E. Stevens et al.

Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region

Brain Res.

(1991)

Cited by (23)

Antagonizing the different stages of kappa opioid receptor activation selectively and independently attenuates acquisition and consolidation of associative memories
2017, Behavioural Brain Research
Citation Excerpt :
PTX is a toxin that selectively catalyzes the ADP-ribosylation of G-proteins, preventing KOR-dependent kinase activation [40]. At the concentration used, PTX blocks KOR mediated behaviors such as morphine self-administration and behavioral sensitization [41,42]. Additionally, Kanbara et al. have demonstrated that a single PTX injection can block morphine dependent behaviors for up to 7 days, suggesting that it has a prolonged duration of action on KOR activation [43].
Previous work from our laboratory has shown that nonspecific kappa opioid receptor (KOR) antagonism in primary somatosensory cortex (S1) can inhibit acquisition for the forebrain-dependent associative task, Whisker-Trace Eyeblink conditioning (WTEB). Although studies have demonstrated that KOR activation can alter stimuli salience, our studies controlled for these factors, demonstrating that KOR also plays a role in facilitating learning. KOR has two distinct phases of activation followed by internalization/downregulation, that each independently activate kinases and transcription factors known to mediate task acquisition and memory consolidation respectively. The current study demonstrated that antagonism of the initial phase of KOR activation in S1 via local injections of the g-protein inhibitor, pertussis toxin (PTX), blocked initial WTEB acquisition without affecting retention of the association. In contrast, KOR late phase antagonism in S1 via local injections of the GRK3-specific antagonist, guanidinonaltrindole (GNTI), blocked retention of the WTEB association without affecting task acquisition. Consistent with the known mechanism for KOR activation, KOR protein expression in S1 was found to be decreased following WTEB training, further supporting the involvement of neocortical KOR activation with learning. Prior studies have shown that task acquisition and memory consolidation are mediated by distinct molecular processes; however, little is known regarding a potential mechanism driving these processes. The current study suggests that neocortical KOR activation mediates activation of these processes with learning. This study provides the first evidence for a time- and learning-dependent property of neocortical KOR in facilitating acquisition and consolidation of associative memories, while elucidating an unexplored neocortical learning mechanism.
Mu opioid receptor activation normalizes temporo-ammonic pathway driven inhibition in hippocampal CA1
2011, Neuropharmacology
Citation Excerpt :
Thus MOR activation should significantly influence both the integration of input and output of CA1 pyramidal neurons. MOR activity in the hippocampus has affects on learning and memory (Corrigall and Linesman, 1988; Stevens et al., 1991; Self and Stein, 1993; but see Olmstead and Franklin, 1997) and may also play a role in chronic morphine tolerance as well as dependence (Fan et al., 1999; Lu et al., 2000; Mitchell et al., 2000). Not surprisingly, MOR activation can modulate synaptic plasticity in hippocampal CA1 and spatial memory in rodents (Mansouri et al., 1997, 1999; Pourmotabbed et al., 1998; Pu et al., 2002; Wagner et al., 2001).
The hippocampus of the mammalian brain is important for the formation of long-term memories. Hippocampal-dependent learning can be affected by a number of neurotransmitters including the activation of μ-opioid receptors (MOR). It has been shown that MOR activation can alter synaptic plasticity and network oscillations in the hippocampus, both of which are thought to be important for the encoding of information and formation of memories. One hippocampal oscillation that has been correlated with learning and memory formation is the 4–10 Hz theta rhythm. During theta rhythms, inputs to hippocampal CA1 from CA3 (Schaffer collaterals, SC) and the entorhinal cortex (perforant path) can integrate at different times within an individual theta cycle. Consequently, when excitatory inputs in the stratum lacunosum-moleculare (the temporo-ammonic pathway (TA), which includes the perforant path) are stimulated approximately one theta period before SC inputs, the TA can indirectly inhibit SC inputs. This inhibition is due to the activation of postsynaptic GABA_B receptors on CA1 pyramidal neurons. Importantly, MOR activation has been shown to suppress GABA_B inhibitory postsynaptic potentials in CA1 pyramidal neurons. Therefore, we examined how MOR activation affects the integration between TA inputs and SC inputs in hippocampal CA1. To do this we used voltage-sensitive dye imaging and whole cell patch clamping from acute hippocampal slices taken from young adult rats. Here we show that MOR activation has no effect on the integration between TA and SC inputs when activation of the TA precedes SC by less than one half of a theta cycle (<75 ms). However, MOR activation completely blocked the inhibitory action of TA on SC inputs when TA stimulation occurred approximately one theta cycle before SC activation (>150 ms). This MOR suppression of TA driven inhibition occurred in both the SC input layer of hippocampal CA1 (stratum radiatum) and the output layer of CA1 pyramidal neurons (stratum pyramidale). Thus MOR activation can have profound effects on the temporal integration between two primary excitatory pathways to hippocampal CA1 and subsequently the resultant output from CA1 pyramidal neurons. These data provide important information for understanding how acute or chronic MOR activation may affect the integration of activity within hippocampal CA1 during theta rhythm.
Evaluation of study design variables and their impact on food-maintained operant responding in mice
2010, Behavioural Brain Research
Operant conditioning paradigms are useful for studying factors involved in reward, particularly when combined with the tools of genetic manipulation in mice. Published operant studies involving mice vary widely with respect to design, and insight into the consequences of design choices on performance in mice is limited. Here, we evaluated the impact of five design variables on the performance of inbred male mice in operant tasks involving solid food pellets as reinforcing agents. We found that the use of lever-press or nose-poke during FR1 sessions did not impact the performance of C57BL/6 mice, but that the lever-press approach correlated with enhanced performance during PR testing. While FR1 session duration had a notable impact on the rate of acquisition of food-maintained responding, performance during FR1 and PR sessions was largely unaffected. Higher order schedules of reinforcement (FR3 and FR5) led to elevated responding during both FR and PR sessions, and improved the correspondence between rewards earned and consumed. Single and group-housed mice performed indistinguishably during FR1 and PR sessions, while environmental enrichment combined with group housing accelerated the rate of acquisition of food-maintained responding while decreasing responding during PR testing. Finally, while C57BL/6 and 129/Sv mice exhibited comparable behavior during FR1 sessions, C57BL/6 mice tended to acquire food-maintained responding faster than 129/Sv counterparts, and exhibited elevated responding during PR testing. Altogether, our findings indicate that while operant performance for food in mice is relatively insensitive to many study parameters, experimental outcomes can be shaped predictably with proper design decisions.
Layer selective presynaptic modulation of excitatory inputs to hippocampal cornu Ammon 1 by μ-opioid receptor activation
2008, Neuroscience
Chronic and acute activation of μ-opioid receptors (MOR) in hippocampal cornu Ammon 1 (CA1) disrupts rhythmic activity, alters activity-dependent synaptic plasticity and impairs spatial memory formation. In CA1, MORs act by hyperpolarizing inhibitory interneurons and suppressing inhibitory synaptic transmission. MOR modulation of inhibitory synaptic function translates into an increase in excitatory activity in all layers of CA1. However, the exact anatomical sites for MOR actions are not completely known. Therefore, we used voltage-sensitive dye imaging, whole cell patch clamping, photolysis of α-carboxy-2-nitrobenzyl ester, trifluoroacetic acid salt (CNB) –caged GABA, and micro-sectioned slices of rat hippocampus to investigate the effect of MOR activation in CA1. First, we investigated the effect of MOR activation using a MOR agonist [d-Ala2, NMe-Phe4, Gly-ol5]-enkephalin (DAMGO) on the direct activation of GABA receptors by photolysis of CNB-caged GABA in all layers of CA1. MOR activation did not affect hyperpolarizations due to direct GABA receptor activation in any layer of CA1, but MOR activation did suppress GABAergic inhibitory postsynaptic potentials suggesting that MOR activation acts by presynaptically inhibiting interneuron function. We next examined whether MOR activation was equivalently effective in all anatomical layers of CA1. To do this, cuts were made between anatomical layers of CA1 and isolated layers were stimulated electrically (five pulses at 20 Hz) to produce excitatory postsynaptic potentials (EPSPs). Under these conditions, MOR activation significantly increased EPSP areas in stratum radiatum (SR), stratum pyramidale (SP) and stratum oriens (SO) relative to stratum lacunosum-moleculare (SLM). When compared with the effect of GABA_A and GABA_B receptor antagonists on EPSP areas, the effect of DAMGO was proportionately larger in SR, SP and SO than in SLM. We conclude that MOR activation is more effective at directly modulating activity in SR, SP and SO, and the smaller effect in SLM is likely due to a smaller MOR inhibition of GABA release in SLM.
Localization of brain reinforcement mechanisms: Intracranial self- administration and intracranial place-conditioning studies
1999, Behavioural Brain Research
Intracranial self-administration (ICSA) and intracranial place conditioning (ICPC) methodologies have been mainly used to study drug reward mechanisms, but they have also been applied toward examining brain reward mechanisms. ICSA studies in rodents have established that the ventral tegmental area (VTA) is a site supporting morphine and ethanol reinforcement. ICPC studies confirmed that injection of morphine into the VTA produces conditioned place preference (CPP). Further confirmation that activation of opioid receptors within the VTA is reinforcing comes from the findings that the endogenous opioid peptide met-enkephalin injected into the VTA produces CPP, and that the mu- and delta-opioid agonists, DAMGO and DPDPE, are self-infused into the VTA. Activation of the VTA dopamine (DA) system may produce reinforcing effects in general because (a) neurotensin is self-administered into the VTA, and injection of neurotensin into the VTA produces CPP and enhances DA release in the nucleus accumbens (NAC), and (b) GABA_A antagonists are self-administered into the anterior VTA and injections of GABA_A antagonists into the anterior VTA enhance DA release in the NAC. The NAC also appears to have a major role in brain reward mechanisms, whereas most data from ICSA and ICPC studies do not support an involvement of the caudate-putamen in reinforcement processes. Rodents will self-infuse a variety of drugs of abuse (e.g. amphetamine, morphine, phencyclidine and cocaine) into the NAC, and this occurs primarily in the shell region. ICPC studies also indicate that injection of amphetamine into the shell portion of the NAC produces CPP. Activation of the DA system within the shell subregion of the NAC appears to play a key role in brain reward mechanisms. Rats will ICSA the DA uptake blocker, nomifensine, into the NAC shell; co-infusion with a D₂ antagonist can block this behavior. In addition, rats will self-administer a mixture of a D₁ plus a D₂ agonist into the shell, but not the core, region of the NAC. The ICSA of this mixture can be blocked with the co-infusion of either a D₁ or a D₂ antagonist. However, the interactions of other transmitter systems within the NAC may also play key roles because NMDA antagonists and the muscarinic agonist carbachol are self-infused into the NAC. The medial prefrontal (MPF) cortex supports the ICSA of cocaine and phencyclidine. The DA system also seems to play a role in this behavior since cocaine self-infusion into the MPF cortex can be blocked by co-infusing a D₂ antagonist, or with 6-OHDA lesions of the MPF cortex. Limited studies have been conducted on other CNS regions to elucidate their role in brain and drug reward mechanisms using ICSA or ICPC procedures. Among these regions, ICPC findings suggest that cocaine and amphetamine are rewarding in the rostral ventral pallidum (VP); ICSA and ICPC studies indicate that morphine is rewarding in the dorsal hippocampus, central gray and lateral hypothalamus. Finally, substance P mediated systems within the caudal VP (nucleus basalis magnocellularis) and serotonin systems of the dorsal and median raphe nuclei may also be important anatomical components involved in brain reward mechanisms. Overall, the ICSA and ICPC studies indicate that there are a number of receptors, neuronal pathways, and discrete CNS sites involved in brain reward mechanisms.
Neurobiology of addiction
1996, Current Opinion in Neurobiology
Addictive drugs have habit-forming actions that can be localized to a variety of brain regions. Recent advances in our understanding of the chemical ‘trigger zones’ in which individual drugs of abuse initiate their habit-forming actions have revealed that such disparate drugs as heroin, cocaine, nicotine, alcohol, phencyclidine, and cannabis activate common reward circuitry in the brain. Although these drugs have many actions that are distinct, their habit-forming actions (and perhaps the relevant elements of their disparate withdrawal symptoms) appear to have a common denominator, namely, similar effects in the brain mechanisms of reward.

View all citing articles on Scopus

¹: Present address: Laboratory of Molecular Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06508.

View full text

Pertussis toxin attenuates intracranial morphine self-administration

Abstract

Brain Res.

Pharmacol. Biochem. Behav.

Brain Res.

J. Neurosci. Methods

Life Sci.

Pharmacol. Biochem. Behav.

Life Sci.

Brain Res.

Neuropharmacology

Neurosci. Lett.

Eur. J. Pharmacol.

Brain Res.

Brain Res.

Pharmacol. Biochem. Behav.

J. Biol. Chem.

Pharmacol. Biochem. Behav.

Eur. J. Pharmacol.

Brain Res.

Brain Res.

Brain Res.